June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Rates of Sample Acquisition in Uveal Melanoma Fine Needle Aspiration Biopsies Using Transscleral and Transvitreal Techniques
Author Affiliations & Notes
  • Amy C Schefler
    Ophthalmology, Retina Consultants of Houston, Houston, TX
    Ophthalmology, Houston Methodist Hospital, Houston, TX
  • Maru Eugenia Bretana
    Ophthalmology, Retina Consultants of Houston, Houston, TX
  • Patricia Chevez-Barrios
    Ophthalmology, Houston Methodist Hospital, Houston, TX
  • Bin Teh
    Ophthalmology, Houston Methodist Hospital, Houston, TX
  • Neda Nikpoor
    Ophthalmology, Bascom Palmer Eye Institute, Miami, FL
  • Daniel Gologorsky
    Ophthalmology, Bascom Palmer Eye Institute, Miami, FL
  • Footnotes
    Commercial Relationships Amy Schefler, None; Maru Bretana, None; Patricia Chevez-Barrios, None; Bin Teh, None; Neda Nikpoor, None; Daniel Gologorsky, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5328. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Amy C Schefler, Maru Eugenia Bretana, Patricia Chevez-Barrios, Bin Teh, Neda Nikpoor, Daniel Gologorsky; Rates of Sample Acquisition in Uveal Melanoma Fine Needle Aspiration Biopsies Using Transscleral and Transvitreal Techniques. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5328.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

The purpose of this study was to compare the rate of successful sample acquisition during uveal melanoma fine needle aspiration biopsies using transscleral versus transvitreal techniques.

 
Methods
 

This was a single-center, retrospective review of patients who chose to undergo fine needle aspiration biopsies for cytopathologic and genomic analyses of uveal melanoma concurrent or before definitive treatment with Iodine-125 plaque or biopsy in 2014. Only patients with 3 months or more of follow-up and adequate data for analysis were included. Clinical variables were reviewed including: patient demographic data (age, sex, right/left eye); clinical tumor data (size of tumor, presence of subretinal fluid, location of tumor); biopsy technique details (transscleral versus transvitreal, number of passes needed, adequacy of sample obtained, GEP class and discriminant value).

 
Results
 

There were 30 patients who met the inclusion criteria. Ten were females and 20 were males. Seventeen of the eyes in the study were right eyes, and 13 were left eyes. The mean age of the patients was 61 (range, 19-82). Seventeen underwent biopsies with a transvitreal approach and 13 underwent biopsies via a transscleral approach. Of the 30 biopsies, only two patients who underwent transvitreal biopsies had an inadequate sample (93% success rate). Sixteen were Gene Expression Profiling Class 1A; Three patients were Class 1B; and 11 were Class 2. Mean discriminant value was 0.86 for the gene expression profiling sample and all patients except one in the study had a discriminant value > 0.1. The vast majority of the time, only one biopsy pass was needed. No patients developed a retinal detachment and transient vitreous hemorrhage occurred in nearly all patients. There were no cases of extraocular extension. Various techniques were used to ensure biopsy success including adequacy checks with the ophthalmic pathologist present in the operating room for the procedure, use of the 27 g vitreous cutter for lesions < 1.5 mm, direct visualization with a retinal viewing system, and others.

 
Conclusions
 

Very high success rates can be achieved with both transscleral and transvitreal approaches to fine needle aspiration biopsy for uveal melanoma using the technical approaches described in this study.

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×